Download full-text PDF

Source
http://dx.doi.org/10.1080/15265161.2014.889243DOI Listing

Publication Analysis

Top Keywords

equipoise nonmedical
4
nonmedical risks
4
equipoise
1
risks
1

Similar Publications

Liver Living Donation for Cancer Patients: Benefits, Risks, Justification.

Recent Results Cancer Res

May 2021

Director Department of Surgery and Transplantation, University Hospital, Hoppe-Seyler-Strasse 3, 72076, Tübingen, Germany.

LDLT covers all standard indications for liver transplantation, and the results are similar or even better than for standard DDLT. Due to the donor shortage and long waiting time, LDLT has become a relevant option for patients with liver tumors, provided the expected five-year survival rate is comparable to that of patients receiving a DDLT. Nowadays, LDLT offers the possibility to extend the standard morphometric selection by considering the biological parameters.

View Article and Find Full Text PDF

Background Youth population has a common tendency to use androgenic steroids. The reasons for such abuse vary from performance enhancement to muscle building in order to enhance physical appearance. Such rampant abuse, aided by fitness centers and gym trainers, has a huge risk of side effects such as hepatic dysfunctions and increased risk of infections.

View Article and Find Full Text PDF

Ethical issues concerning therapeutic studies in inflammatory bowel disease.

Inflamm Bowel Dis

September 2007

Division of Gastroenterology and Hepatology, Fiterman Center, Mayo Clinic College of Medicine, Rochester, Minnesota, USA.

Physicians often take on responsibilities beyond medical care regarding their patients with ulcerative colitis and Crohn's disease: they serve as the patients' advocates to nonmedical entities and individuals, including insurance companies, schools, employers, companions, and family members. These responsibilities create a more complex relationship between the patient and their IBD physician. In addition, these responsibilities may accentuate ethical issues for the physician who is also engaged in clinical treatment trials for inflammatory bowel disease (IBD).

View Article and Find Full Text PDF

Randomised controlled trials (RCTs) play a central role in modern medical advance, and they require participants who understand and accept the procedures involved. Published evidence suggests that RCT participants often fail to understand that treatments are allocated at random and that clinicians are in equipoise about which treatment is best. We examine background assumptions that members of the public might draw upon if invited to take part in a RCT.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!